Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

CHRSCHRS
31 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in COHERUS ONCOLOGY INC

GEODE CAPITAL MANAGEMENT, LLC holds 3.7M shares of CHRS (COHERUS ONCOLOGY INC), worth $5.2M as of 2026-Q2. The position was increased (+18.1% shares). CHRS represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$5.2M

Current Shares

3.7M

Total Value Change

-$6.2M

Total Shares Change

+2.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.7M
+18.1%
$5.2M0.0%$1.40
32
2026-Q1
Increased
3.1M
+13.7%
$5.3M0.0%$1.65
31
2025-Q4
Increased
2.7M
+0.1%
$3.9M0.0%$1.41
27
2025-Q3
Increased
2.7M
+2.4%
$4.5M0.0%$1.70
27
2025-Q2
Increased
2.7M
+0.8%
$2M0.0%$0.74
26
2025-Q1
Increased
2.7M
+2.1%
$2.1M0.0%$0.84
26
2024-Q4
Increased
2.6M
+1.3%
$3.6M0.0%$1.50
27
2024-Q3
Increased
2.6M
+7.7%
$2.7M0.0%$1.05
28
2024-Q2
Increased
2.4M
+8.1%
$4.1M0.0%$1.73
29
2024-Q1
Increased
2.2M
+5.9%
$5.3M0.0%$2.39
29
2023-Q4
Increased
2.1M
+7.0%
$6.9M0.0%$3.33
29
2023-Q3
Increased
1.9M
+36.9%
$7.3M0.0%$3.74
36
2023-Q2
Increased
1.4M
+8.6%
$6.1M0.0%$4.19
30
2023-Q1
Increased
1.3M
+3.8%
$8.9M0.0%$6.43
29
2022-Q4
Increased
1.3M
+2.5%
$10M0.0%$7.92
28
2022-Q3
Increased
1.2M
+2.7%
$11.8M0.0%$9.35
29
2022-Q2
Increased
1.2M
+2.5%
$8.7M0.0%$7.40
28
2022-Q1
Decreased
1.2M
-2.2%
$15.1M0.0%$12.84
0
2021-Q4
Decreased
1.2M
-0.3%
$19.1M0.0%$16.74
0
2021-Q3
Increased
1.2M
+1.2%
$19.2M0.0%$16.46
29
2021-Q2
Increased
1.2M
+7.7%
$16.4M0.0%$14.04
30
2021-Q1
Increased
1.1M
+11.3%
$16.1M0.0%$14.45
31
2020-Q4
Increased
987,470
+3.1%
$17.2M0.0%$17.57
29
2020-Q3
Increased
958,060
+0.3%
$17.6M0.0%$18.81
28
2020-Q2
Decreased
954,959
-1.4%
$17.1M0.0%$17.33
0
2020-Q1
Decreased
968,982
-45.8%
$15.7M0.0%$16.79
0
2019-Q4
Increased
1.8M
+108.8%
$32.2M0.0%$17.54
47
2019-Q3
Increased
856,569
+8.3%
$17.4M0.0%$20.48
31
2019-Q2
Increased
790,963
+13.5%
$17.5M0.0%$22.10
32
2019-Q1
Decreased
696,985
-44.7%
$9.5M0.0%$13.64
0
2018-Q4
New
1.3M
-
$11.4M0.0%$8.93
39

Other major holders of CHRS: BNP PARIBAS FINANCIAL MARKETS, Temasek Holdings (Private) Ltd

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used